Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry.
Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry. The company's products and services include in vitro assay protocols, in vitro throughput screening and compound profiling services, custom assay development, enzymology services, and lead discovery/lead optimization partnering programs. It offers drug discovery contract research services, HTS, profiling and lead generation, and lead optimization solutions. The company serves pharmaceutical and biopharmaceutical companies, emerging biotechnology companies, and research foundations. Amphora Discovery Corporation was founded in 2001 and is headquartered in Durham, North Carolina. As of July 2008, Amphora Discovery Corporation operates as a subsidiary of Nanosyn Inc.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 24, 2006 | Series E | $4.37M | 3 | — | — | Detail |
Jun 15, 2005 | Series D | $9.55M | 2 | — | — | Detail |
Dec 8, 2004 | Series C | $20M | 2 | — | — | Detail |
Jan 6, 2004 | Series B | $12.90M | 2 | — | — | Detail |
Dec 26, 2002 | Series B | $12.48M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series E |
Genavent | — | Series E |
Versant Ventures | — | Series E |